DrugDashboards

Market view

mercurius solubilis, candida albicans

1 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for mercurius solubilis, candida albicans, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Lymphastat CJul 29, 2026
    Mfr exited
    Energique, Inc. · mercurius solubilis, candida albicans
  • Lymphastat CJul 22, 2026
    Mfr entered
    Energique, Inc. · mercurius solubilis, candida albicans

Same drug class

Other molecules FDA puts in Non-Standardized Fungal Allergenic Extract, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Mercurius solubilis, candida albicans in shortage right now?
No. FDA does not currently list Mercurius solubilis, candida albicans in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Mercurius solubilis, candida albicans?
1 company has marketed Mercurius solubilis, candida albicans in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.